Seeking Alpha

Neuralstem, Inc. (CUR)

There are 7 articles on this stock available only to PRO subscribers.
From other sites
CUR vs. ETF Alternatives
Company Description
Neuralstem, Inc. is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.
Sector: Healthcare
Industry: Biotechnology
Country: United States